Professor Tuomas Knowles in Cambridge before the coronavirus lockdown
May 20 2020
Professor Tuomas Knowles and his colleagues are developing a new approach to help better understand the body’s defences against SARS-CoV-2, and ultimately support the development of reliable antibody tests and vaccines.
New hope for weight-loss drug without harmful side effects
May 11 2020
Researchers here have developed a potential weight loss drug and shown in mice that it may also avoid the harmful side effects of traditional treatments.
Targeting oligomer dynamics provides hope for new Alzheimer’s therapies
Lead author Dr Thomas Michaels developed a maths model
Apr 12 2020
Researchers have revealed for the first time the surprising behaviour of toxic oligomers in the amyloid aggregation process involved in Alzheimer’s and other diseases, thus opening up routes for new therapies against these dreaded killers.
Matt Bushen and NIck Bampos deliver PPE to Addenbrooke's, courtesy Department of Chemistry
Apr 11 2020
The Department of Chemistry has delivered safety glasses and gloves to Addenbrooke's Hospital to support local NHS staff in the battle against COVID-19.
Using visible light to trigger the union of feedstocks
Image of Matthew Gaunt: Department of Chemistry Photography
Apr 8 2020
A new chemical transformation using visible light to trigger the union of readily available feedstocks has enabled researchers to produce complex tertiary alkylamines in a single step. This could streamline the synthesis of novel small molecules.
Although he hasn't been studying the virus itself, Professor Rod Jones has been investigating an unexpected positive consequence of the virus caused by movement restrictions imposed by the government during the coronavirus pandemic.
Researchers here who normally design antibodies for use against Alzheimer’s disease are now redirecting the same approach to develop antibodies against the coronavirus.
